Marex Group plc Sets Terms for Public Offering
Marex Group plc, a prominent diversified global financial services platform, recently unveiled the pricing details of its public offering of 10,283,802 ordinary shares. The shares have been priced at $35.50 each, signalling a significant move for the company. Notably, the offering involves certain selling shareholders who have also granted underwriters a 30-day option to acquire an additional 1,542,570 ordinary shares. This strategic decision is designed to provide added flexibility in the market.
Understanding the Offering Details
It is essential to clarify that Marex Group plc is not participating by selling any of its own ordinary shares in this offering. As such, Marex will not benefit financially from the transaction, as any proceeds will solely benefit the selling shareholders. The closing of the offering is expected to occur shortly, subject to standard closing conditions generally associated with such transactions.
Role of Underwriters
A team of reputable financial institutions is managing this offering. Goldman Sachs & Co. LLC, Barclays, and Jefferies have stepped in as the lead book-running managers and representatives for the underwriters. In addition, other notable firms including UBS Investment Bank, Keefe, Bruyette & Woods, a Stifel Company, Piper Sandler & Co., TD Securities, and Berenberg are also participating as bookrunners for the offering. Their involvement highlights the robust interest and confidence in Marex's market position.
How to Obtain the Prospectus
If you are interested in the offering, it’s important to note that it is exclusively conducted through a formal prospectus. This means potential investors should take the necessary steps to review the prospectus, which provides crucial information. Investors can acquire copies by reaching out to the respective firms involved, including Goldman Sachs, Barclays, and Jefferies, each providing contact methods through email and telephone.
Regulatory Framework
The registration statement pertinent to this offering has been filed with the U.S. Securities and Exchange Commission (SEC) and has received the necessary status to proceed. However, it is crucial for potential investors to understand that this press release is not an invitation to buy or sell shares in jurisdictions where such actions may violate local laws.
Considering Forward-Looking Statements
The release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. It's important to remember that these statements, which often include expectations about future events, come with inherent uncertainties and risks. Factors like geopolitical issues, market volatility, and regulatory changes may affect these projections. Therefore, actual outcomes may significantly deviate from what is presented in any future statements.
Contact Information
For further inquiries, you can contact Nicola Ratchford or Adam Strachan at Marex Group. They can be reached at +44 (0) 778 654 8889 for local calls or +1 914 200 2508 for international queries. For email correspondence, you may reach out to them directly at nratchford@marex.com and astrachan@marex.com. Additionally, FTI Consulting can assist with communication needs, providing contact details for further engagement.
Frequently Asked Questions
What is the price per share for the offering?
The shares are priced at $35.50 each as part of the public offering.
Who are the underwriters for the offering?
Goldman Sachs & Co. LLC, Barclays, and Jefferies are the lead underwriters, supported by several other financial institutions.
Will Marex receive any funds from this offering?
No, Marex is not selling any of its ordinary shares in this offering and will receive no proceeds.
How can I obtain the prospectus for the offering?
Copies of the prospectus can be requested from Goldman Sachs, Barclays, or Jefferies directly via phone or email.
What should I be aware of regarding forward-looking statements?
Forward-looking statements involve risks and uncertainties and may not guarantee future performance, as various factors can influence outcomes.
